AstraZeneca and Oracle will use AI and real patient health data to find people for drug trials faster, the two firms announced. The deal adds to a long list of AI health tie-ups between drugmakers and tech companies. The pair signed a non-binding term sheet, so the terms are not yet final, and neither firm said or […]This story continues at The Next Web